CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and due from banks	$ 444,690	$ 444,325
Interest bearing deposits with banks	5,260,998	503,622
Investment securities:
Equity securities	50,152	48,731
Trading debt securities	6,855	13,438
Available for sale debt securities	1,259,236	1,261,397
Held to maturity debt securities (net of allowance for credit losses of $1,633 at March 31, 2023 and $1,646 at December 31, 2022)	3,845,579	3,827,338
Total investment securities	5,161,822	5,150,904
Loans held for sale, at fair value	17,218	18,118
Loans	48,659,966	46,917,200
Less: Allowance for loan losses	(436,898)	(458,655)
Net loans	48,223,068	46,458,545
Premises and equipment, net	365,313	358,556
Lease right of use assets	302,740	306,352
Bank owned life insurance	717,339	717,177
Accrued interest receivable	223,608	196,606
Goodwill	1,868,936	1,868,936
Other intangible assets, net	187,171	197,456
Other assets	1,536,670	1,242,152
Total Assets	64,309,573	57,462,749
Deposits:
Non-interest bearing	13,576,116	14,463,645
Interest bearing:
Savings, NOW and money market	22,903,424	23,616,812
Time	11,111,376	9,556,457
Total deposits	47,590,916	47,636,914
Total short-term borrowings	6,413,056	138,729
Long-term borrowings	2,197,656	1,543,058
Junior subordinated debentures issued to capital trusts	56,847	56,760
Lease liabilities	355,020	358,884
Accrued expenses and other liabilities	1,184,497	1,327,602
Total Liabilities	57,797,992	51,061,947
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 507,896,910 shares at March 31, 2023 and December 31, 2022)	178,186	178,185
Surplus	4,967,662	4,980,231
Retained earnings	1,300,980	1,218,445
Accumulated other comprehensive loss	(143,647)	(164,002)
Treasury stock, at cost (134,552 common shares at March 31, 2023 and 1,522,432 common shares at December 31, 2022)	(1,291)	(21,748)
Total Shareholders’ Equity	6,511,581	6,400,802
Total Liabilities and Shareholders’ Equity	64,309,573	57,462,749
Series A
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	$ 98,101	$ 98,101